Search Results - David Wirta
- Showing 1 - 12 results of 12
-
1
-
2
-
3
ONSET-1 Phase 2b Randomized Trial to Evaluate the Safety and Efficacy of OC-01 (Varenicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye Disease by David Wirta, Gail Torkildsen, Blair Boehmer, David Hollander, Edward Bendert, Lijuan Zeng, Michael Ackermann, Jeffrey Nau
Published 2021Artigo -
4
Efficacy and Safety of a Water-Free Topical Cyclosporine, 0.1%, Solution for the Treatment of Moderate to Severe Dry Eye Disease by Esen K. Akpek, David Wirta, Johnathon Downing, Joseph Tauber, John D. Sheppard, Joseph B. Ciolino, Alice S. Meides, Sonja Krösser
Published 2023Artigo -
5
A Clinical Phase II Study to Assess Efficacy, Safety, and Tolerability of Waterfree Cyclosporine Formulation for Treatment of Dry Eye Disease by David Wirta, Gail Torkildsen, Helen R. Moreira, John Lonsdale, Joseph B. Ciolino, Garrit Jentsch, Michael Beckert, George W Ousler, Philipp Steven, Sonja Krösser
Published 2019Artigo -
6
A Water-free 0.1% Cyclosporine A Solution for Treatment of Dry Eye Disease: Results of the Randomized Phase 2B/3 ESSENCE Study by John D. Sheppard, David Wirta, Eugene McLaurin, Blair Boehmer, Joseph B. Ciolino, Alice S. Meides, Thomas Schlüter, George W Ousler, Dale W. Usner, Sonja Krösser
Published 2021Artigo -
7
-
8
Long-term Safety and Efficacy of a Sustained-Release Bimatoprost Ocular Ring by James D. Brandt, Harvey Dubiner, Robert Benza, Kenneth Sall, Gary Walker, Charles P. Semba, Donald L. Budenz, Douglas G. Day, Brian Flowers, Steven J. Lee, Quang H. Nguyen, David Wirta
Published 2017Artigo -
9
Efficacy and Safety of OC-01 (Varenicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye Disease by David Wirta, Patrick Vollmer, James D. Paauw, Kuei-Hsun Chiu, Eugenia Henry, Kristen Striffler, Jeffrey Nau, David Wirta, Jay Rubin, Charles Reilly, Lance Bergstrom, Karl R. Olsen, Gary Jerkins, Guruprasad R. Pattar, Bruce Segal, Carol Aune, John D. Goosey, Joel A. Geffin, Daniel Terveen, Kenneth R. Kenyon, Jung Dao, Kenneth R. Kenyon, Jared D. Peterson, Daniel P. Zimmer, Patrick Vollmer, Blair Boehmer, James D. Paauw, Yen Nieman, Eva Liang
Published 2021Artigo -
10
Six-Month Intraocular Pressure Reduction with a Topical Bimatoprost Ocular Insert by James D. Brandt, Kenneth Sall, Harvey Dubiner, Robert Benza, Yair Alster, Gary Walker, Charles P. Semba, Donald L. Budenz, Douglas G. Day, Brian Flowers, Steven J. Lee, Quang H. Nguyen, David Wirta
Published 2016Artigo -
11
Once-Daily Netarsudil Versus Twice-Daily Timolol in Patients With Elevated Intraocular Pressure: The Randomized Phase 3 ROCKET-4 Study by Albert S Khouri, Janet B. Serle, Jason Bacharach, Dale W. Usner, Richard A. Lewis, Puiwah Braswell, Casey Kopczynski, Theresa Heah, Jason Bacharach, Robert Benza, John W. Boyle, Michelle R. Butler, Leonard Robert Cacioppo, José F. Cardona, Valerie A. Colborn, Douglas G. Day, David T. Douglass, Shérif M. El-Harazi, Deepta Ghate, Carl G. Hartman, Robert F. Haverly, Barry Katzman, Max Kim, Edward Y. Koo, Michael Korenfeld, Bradley Kwapiszeski, Lydia Spencer Lane, Christopher Lin, Andrew Gardner Logan, Jeffrey Raymond Lozier, Henry McQuirter, Thomas K. Mundorf, Kenneth W. Olander, Richard Ou, Gregory J. Panzo, James H. Peace, Eugene Protzko, Robert Ritch, Kenneth Sall, Barry A. Schechter, Samuel Eric Seltzer, Pankajkumar G. Shah, Elizabeth Sharpe, Philip Lee Shettle, David G. Shulman, Inder Paul Singh, Stacy Smith, Stephen Smith, Robert Smyth-Medina, Robert C. Sorenson, Richard T. Sturm, Gregory M. Sulkowski, James D. Sutton, Michael Tepedino, Julie H. Tsai, Carl B. Tubbs, David B. Tukel, Thomas R. Walters, David Wirta
Published 2019Artigo -
12
Phase 3, Randomized, 20-Month Study of the Efficacy and Safety of Bimatoprost Implant in Patients with Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 2) by Jason Bacharach, Andrew J. Tatham, Gloria E. Ferguson, Sandra Belalcázar, Hagen Thieme, Margot L. Goodkin, Michelle Y. Chen, Qiang Guo, Jeen Liu, Michael R. Robinson, Marina Bejanian, David Wirta, Arturo Alezzandrini, Gabriel Bercovich, Pablo Deromedis, Federico Furno Sola, Carolina Gentile, S. Lerner, Anahi Lupinacci, Carlos Zeolite, Catherine M. Birt, Andrew Crichton, Sébastien Gagné, Michael Giunta, Paul Harasymowycz, Delan Jinapriya, Marcelo T. Nicolela, Donald R. Nixon, Patrick Saurel, David Yan, Darana Yuen, Santiago Arango, Sandra Belalcázar, Alexander Martínez, Juan Camilo Restrepo, Vladimír Korda, Jana Kadlecová, Jitka Svačinová, Hany A. Khairy, Hani El Ibiary, Zeinab El Sanabary, Katharina Bell, Roman Greslechner, Joerg Michael Koch, K Lorenz, Isabel Oberacher-Velten, Stefanie Schmickler, C Schuart, Hagen Thieme, Francesco Bandello, Carlo Cagini, Michele Figus, Leonardo Mastropasqua, Luca Rossetti, Maurizio G. Uva, Sandragasu Thayanithi, Anthony P. Wells, Rahat Husain, Victor Koh, Dawn Lim, Tin Aung, Petrus Gous, Lynette Venter, Changwon Kee, Michael S. Kook, Ki Ho Park, Muhsin Eraslan, Özcan Kayıkçıoğlu, Nilgün Yıldırım, Rupert Bourne, Anshoo Choudhary, M. Francesca Cordeiro, Vincent Dubois, James Kirwan, Sheng Yang Lim, Keith R. Martin, Antony Nithy, Avinash Prabhu, Andrew J. Tatham, Ahmad Amir, Jason Bacharach, Howard Barnebey, Allen D. Beck, Lance Bergstrom, Navaneet S.C. Borisuth, James D. Branch, Jonathan Briggs, Stephen Bylsma, Peter Chang, William C. Christie, Frank Cotter, Michael Depenbusch, Damien F. Goldberg, Jack V. Greiner, Shailesh Gupta, Ron Gutmark, Ying Han, Sebastian Heersink, Malik Y. Kahook, Albert S Khouri
Published 2021Artigo
Search Tools:
Related Subjects
Medicine
Internal medicine
Randomized controlled trial
Adverse effect
Ophthalmology
Surgery
Clinical endpoint
Anesthesia
Ocular hypertension
Tolerability
Bimatoprost
Intraocular pressure
Visual analogue scale
Confidence interval
Dermatology
Dosing
Glaucoma
Timolol
Biology
Blepharitis
Botany
Demodex
Dysgeusia
Engineering
Environmental health
Erythema
Gastroenterology
Geometry
Implant
Insert (composites)